cancer treatmentIncluding mebendazole to treatment with either lomustine or temozolomide for individuals with recurrent glioblastoma didn't bring about a meaningful scientific benefit.Some systemic indicators of cancer are because of hormones or other molecules made by the tumor, referred to as paraneoplastic syndromes.Some treatments can interfere